Changes of parameters of hemodynamics and systems of neurohumoral regulation in patients with implanted cardiac pacemakers after switching from DDD to VVI pacing mode

Kardiologiya

Volumn 46, Issue 11, 2006, Pages 66-70

  Chikin, P A ^a   Kiktev, V G ^a   Storozhilova, A N ^a   Sergakova, L M ^a   Masenko, V P ^a   Golitsin, S P ^a  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

Author keywords

Electrical cardiac pacing, modes; NT pro BNP; ODD; pro ANP; VVI

Indexed keywords

ALDOSTERONE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; NORADRENALIN; RENIN;

ARTICLE; ARTIFICIAL HEART PACEMAKER; BLOOD; CONGESTIVE HEART FAILURE; EQUIPMENT DESIGN; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; VASCULAR RESISTANCE;

ALDOSTERONE; BIOLOGICAL MARKERS; EQUIPMENT DESIGN; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NOREPINEPHRINE; PACEMAKER, ARTIFICIAL; PROGNOSIS; RENIN; VASCULAR RESISTANCE;

EID: 33845932773     PISSN: 00229040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Rosenquist M. et al. Long-term pacing in sinus node disease: Effects of stimulation mode on cardiovascular morbidity and mortality. Am Heart J 1988;116:1:Pt 1:16-22.
2. Zanini R. et al. Morbidity and mortality of patients with sinus node disease: comparative effects of atrial and ventricular pacing. PACE 1990; 13: 2076-2079.
3. Stangl K. et al. Differences between atrial single chamber pacing (AAI) and ventricular single chamberpacing (VVI) with respect to prognosis and antiarrhythmic effect in patients with SSS. PACE 1990;13:863-868.
4. Heldman D., Mulvihill D. et al. True incidence of pacemaker syndrome. PACE 1990;13:1742-1750.
5. Baig M.W., Perrins E.J. The hemodynamics of cardiac pacing: clinical and physiological aspects. Prog Cardiovasc Dis 1991;33:283-298.
6. Ellenbogen K.A., Mohanty P.K. New insights into pacemaker syndrome gained from hemodynamic, humoral and vascular responses during ventriculoatrial pacing. Am J Cardiol 1990;65:53-59.
7. Rediker D.E., Eagle K.A., Homma S. et al. Clinical and hemodynamic comparison of VVI versus DDD pacing in patients with DDD pacemakers. Am J Cardiol 1988;61:323-329.
8. Pearson A.C., Janosik D.L., Redd R.M. Hemodynamic benefit of atrioventricular synchrony: prediction from baseline Doppler echocardiographic variables. J Am Coll Cardiol 1989;13:1613-1621.
9. Oldroyd K. et al. Double blind crossover comparisons of the effects of dual chamber pacing (DDD) and ventricular rate adaptive (VVIR) pacing on neuroendocrine variables, exercise performance, and symptoms in complete heart block. Br Heart J 1991;65:188-193.
10. Reynolds D.W., Wilson M.F., Burow R.D. et al. Hemodynamic evaluation of atrioventricular sequential vs. ventricular pacing in patients with normal and poor ventricular function at variable heart rates and posture. J Am Coll Cardiol 1983; 1:636.
11. Sassara M., Achilli A., Bianchi S. et al. Long-term effectiveness of dual site left ventricular cardiac resynchronization therapy in a patient with congestive heart failure. Pacing Clin Electrophysiol 2004;27:6:Pt 1:805-807.
12. Alicandri C., Fonad F. et al. Hypotension and syncope with ventncular pacing: possible role of atrial reflexes. Am J Cardiol 1978;42:137-142.
13. George N. T., Fotis P. et al. Left atrial function and atrial natriuretic factor/cyclic guanosine monophosphate changes in DDD and VVI pacing modes. Am J Cardiol 1997;79:366-370.
14. Menozzi C., Brignole M. et al. Intrapatient comparison between chronic VVIR and DDD pacing in patients affected by high degree AV block without heart failure. PACE 1990;13:12: Pt 2:1816-1822.
15. Russian source
16. Russian source
17. Lewis M.E., Sung R.J., Alter B.R., Myerburg R.J. Pacemaker-induced hypotension. Chest 1981;79:354-356.
18. Hull R.W., Snow F., Herre J., Ellenbogen K.A. The plasma catecholamine responses to ventricular pacing: implications for rate-responsive pacing. PACE 1990;13:1408-1415.
19. Fujik A., Tani M., Mizumaki K. et al. Pacemaker syndrome evaluated by cardiopulmonary exercise testing. PACE 1990;13:1236-1241.
20. Seino Y., Shimai S., Nagae Y. et al. Cardiodynamic and Neurohormonal Importance of Atrial Contribution in Rate-Responsive Pacing. PACE 1993;11:1367-1372.
21. Sloot J.A. New developments in the management of heart failure. Neth J Med 2003;61:19-27.
22. Hole T., Hall C, Skaerpe T. N-terminal proatrial natriuretic peptide predicts two-year remodeling in patients with acute transmural myocardial infarction. Eur Heart J 2004;25:416-423.
23. Hildebrandt P., Boesen M., Olsen M. el al. N-terminal pro brain natriuretic peptide in arterial hypertension-a marker for left ventricular dimensions and prognosis. Eur J Heart Fail 2004;6:313-317.
24. Cabello J.B., Bordes P. et al. Acute and chronic changes in atrial natriuretic factor induced by ventricular pacing: a self-controlled clinical trial. PACE 1996;19:815-821.
25. Maeda K., Tsutamoto T. el al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998;135:825-832.